Delivery Order SPE2DR25D1106-SPE2DR26FJE8B
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a ceiling value of $1,151.04. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30, with a contract ceiling value of $1,733.90. This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, representing a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $6,130.99 under a firm fixed-price arrangement, with an ultimate completion date of November 17, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ondansetron ODT 4 mg tablets in a quantity of 30 units. This firm fixed price delivery order, valued at $10,217.96, represents a non-set-aside competitive award with an ultimate completion date of December 4, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units, valued at $3,532.04. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The contract specifies an ultimate completion date of December 15, 2025, and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance....
- The Defense Logistics Agency awarded a delivery order valued at $1,607.95 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply). This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on December 16, 2025, with an ultimate completion date of December 17, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,499.65 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed-price delivery order with completion scheduled for December 10, 2025, and represents a non-competitive set-aside contract. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units, with a ceiling value of $7,362.92. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for ultimate completion by December 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Ondansetron ODT 4 mg tablets in a quantity of 30 units, with a contract ceiling value of $2,421.15. This is a firm fixed price delivery order with an ultimate completion date of December 12, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a competitively awarded, non-set-aside contract with a ceiling value of $1,457.40 and a firm fixed price structure. The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 11, 2025. This delivery...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJE8BDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 21, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order has a ceiling value of approximately $12,000 and a firm fixed price structure, with an ultimate completion date of December 22, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $1 billion and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen leverages this IDC vehicle to supply a broad range of medications and medical commodities to military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of competitively awarded delivery orders demonstrates its capability to meet federal pharmaceutical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 12/20/25 |